Trials / Completed
CompletedNCT07277192
HAIC vs. TACE Combined With ICIs and TKIs in Intermediate-to-Advanced HCC: A Multicenter Study on Liver Injury and Survival
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 562 (actual)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare the liver injury induced by HAIC combined with PD-1/PD-L1 inhibitors and TKIs versus triple therapy with TACE in the treatment of patients with advanced HCC; to compare the efficacy of the two triple therapy regimens in the treatment of patients with advanced HCC.
Conditions
- Hepatecellular Carcinoma
- Liver Injury
- HAIC(Hepatic Artery Infusion Chemotherapy)
- TACE(Transcatheter Arterial Chemoembolization)
Timeline
- Start date
- 2023-10-01
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2025-12-11
- Last updated
- 2025-12-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07277192. Inclusion in this directory is not an endorsement.